Artiva Biotherapeutics, Inc. (ARTV) Historical Stock Prices
Artiva Biotherapeutics, Inc. (ARTV) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ARTV
CIK: 1817241
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerMelody Stutzman
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-07 | 2026-10-06 | 4 | 0001193125-26-416953 | View SEC Doc Filr Page |
| 144 | 2026-10-06 | — | 144 Filing | 0001950047-26-010072 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-05 | 4 | 0001193125-26-415531 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-05 | 4 | 0001193125-26-415529 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-05 | 4 | 0001193125-26-415528 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-05 | 4 | 0001193125-26-415527 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-15 | 4 | 0001193125-26-392025 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-391012 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 Filing | 0001231919-26-001173 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390558 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390540 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390534 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390531 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390527 | View SEC Doc Filr Page |
| 4 | 2026-09-14 | 2026-09-10 | 4 | 0001193125-26-390524 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-09 | 4 | 0001193125-26-389514 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-09 | 4 | 0001193125-26-389512 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-09 | 4 | 0001193125-26-389511 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-09 | 4 | 0001193125-26-389510 | View SEC Doc Filr Page |
| S-8 | 2026-09-11 | — | S-8 | 0001193125-26-389428 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-08 | 8-K | 0001193125-26-389308 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-08 | 4 | 0001193125-26-386431 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-08 | 4 Filing | 0001231919-26-001152 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-08 | 4 | 0001193125-26-385419 | View SEC Doc Filr Page |
| 4 | 2026-09-08 | 2026-09-08 | 4 | 0001193125-26-385418 | View SEC Doc Filr Page |